CClinicalTrials.gg
Status unknownNCT05310188Updated Apr 4, 2022

Cholinesterase, Amylase, Lipase and Neutrophil-to-lymphocyte Ratio in Acute Pesticide Poisoning Cases

An observational study in Pesticide Poisoning, sponsored by Assiut University. Status unknown. Per ClinicalTrials.gov, last updated 2022-04-04.

Sponsored by Assiut University · Observational

The sponsor has not verified this record recently (last verified Apr 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
100
Sex
All
01

Study summary

To estimate diagnostic levels of amylase, lipase, pseudocholinestrase and neutrophili lymphocytic ratio to different pesticide poisoning.

In addition to detect prognostic values of theses enzymes \& NLR and its relation to the outcome of all pesticide poisoning.

To assess descriptive sociodemographic criteria of these poisoned cases, mode of toxicity, type of pesticide poisoning at emergency room, any other associated toxicity as well as the clinical outcome.

Read the detailed description

Acute pesticide poisoning is a global health problem responsible for majority of deaths in poisoning cases.

There is a study estimated that about 385 million cases of unintentional acute pesticide poisoning occur annually world-wide including about 11,000 fatalities.

Thirty percent of global suicides are due to pesticide poisoning as they are of low cost and easily accessible.

Most common suicidal pesticide are classified according to WHO to organophosphorus insecticides, carbamate insecticide, and methyl parathion /or the herbicide paraquat.

. Aluminum phosphide(ALP) becomes one of the commonest causes of poisoning. It is extremely toxic after self-poisoning, with a case fatality often exceeding 70% after ingestion.

Severe poisoning also has the potential to induce multi-organ failure. The exact site or mechanism of its action has not been proved in humans. Rather than targeting a single organ to cause gross damage.

organophosphorus pesticides inhibit acetylcholine esterase enzyme so that lead to accumulation of Ach and muscarinic, nicotinic and central nervous system (CNS) receptor overstimulation. The severity of acute poisoning depends on level of cholinesterase.

Detection of pseudocholinestrase is a good biomarker and the most specific lab test of acute pesticide poisoning.

There is a relative relationship between plasma cholinesterase and manifestation and final outcome so that level of PChE is a good prognostic value and could help in treatment plans.

Cholinergic stimulation of pancreas leads to hyperamylasemia so amylase could be used as a prognostic tool of acute pesticide poisoning, lipase can be helpful with amylase for early detect of pancreatitis as well as determination of severity of poisoning.

The neutrophil-to-lymphocyte ratio (NLR) is an independent predictor of short- and long-term mortality in critically ill patients, and measurement is simple, cheap, and fast Furthermore, the NLR is a powerful prognostic predictor of cardiovascular affection, acute ischemic stroke, and many other diseases. So high NLR is associated with the risk of mortality of acute toxicity.

laboratory evaluation through using rapid, simple, cheap tests plays an important and vital role for confirmation of poisoning, diagnosing the first acute organ damage as well as assessing the severity of poisoning.

Emergency physicians can help in improvement of these patient and reduce deaths by accurate assessment of lab markers.

02

Conditions studied

  • Pesticide Poisoning

Browse trials for

Keywords

  • cholinesterease
  • lipase
  • amylase
  • NL ratio
03

In context

Poisoning

209 studies on the registry are indexed under Poisoning; 26 are open to participants now.

This study's planned enrollment of 100 is below the median of 121 across 94 observational studies indexed under Poisoning.

Browse Poisoning studies →

Lead sponsor

Assiut University is the lead sponsor of 4,916 studies on the registry; 2,113 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Probability sample

Study population

  • Sociodemographic criteria: age, gender, residence, occupation, level of education,
  • Toxicity associated data: mode of exposure, time of exposure, symptoms appear, any measures done to reduce the toxicity before reaching the hospital
  • Medical history (HR, BP, kidney function, liver function and blood glucose level)
  • Clinical lab result of pseudocholinesterase, amylase, lipase and neutrophil-to-lymphocyte ratio at three times.

    • the first with 6 hrs. of admission
    • the second after 24 hrs. of the treatment regimen taken
    • the third after 48 hrs

Inclusion criteria

  • All ages
  • Both sex
  • Any possible route of exposure to pesticides

Exclusion criteria

Exclusion Criteria:

  • Exposure to medications or toxic chemicals other than pesticides.
  • Patients with chronic comorbidities, including liver cirrhosis, symptomatic heart failure, end stage CKD(on regular hemodialysis) and COPD.
  • Patients with gallstone history or DM
  • Recent abdominal trauma
  • Open abdominal surgery within one year ago
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Interventions

  • Diagnostic testpseudocholinesterease

    blood samples

    Also known as: lipase, NLR, amylase

06

What researchers measure

Primary outcomes

  1. Diagnostic and prognostic values of cholinesterase in acute pesticide poisoning cases

    clinical lab result of pseudocholinesterase

    Time frame: baseline

  2. diagnostic and prognostic value of amylase in acute pesticide poisoning cases

    blood level of amylase

    Time frame: baseline

  3. diagnostic and prognostic value of lipase in acute pesticide poisoning cases

    blood level of lipase

    Time frame: baseline

  4. diagnostic and prognostic value of neutrophil-to-lymphocyte ratio in acute pesticide poisoning case

    blood level of neutrophil-to-lymphocyte ratio

    Time frame: baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Afzali S, Taheri SK, Seifrabiei M. Butyrylcholinesterase level in poisoned patients with phosphide compounds. Caspian J Intern Med. 2019 Fall;10(4):458-462. doi: 10.22088/cjim.10.4.458. PubMed 31814946 ↗
  • Boedeker W, Watts M, Clausing P, Marquez E. The global distribution of acute unintentional pesticide poisoning: estimations based on a systematic review. BMC Public Health. 2020 Dec 7;20(1):1875. doi: 10.1186/s12889-020-09939-0. PubMed 33287770 ↗
  • Mu Y, Hu B, Gao N, Pang L. Prognostic value of the neutrophil-to-lymphocyte ratio in acute organophosphorus pesticide poisoning. Open Life Sci. 2021 Jul 15;16(1):703-710. doi: 10.1515/biol-2021-0069. eCollection 2021. PubMed 34307885 ↗
  • Mehrpour O, Jafarzadeh M, Abdollahi M. A systematic review of aluminium phosphide poisoning. Arh Hig Rada Toksikol. 2012 Mar;63(1):61-73. doi: 10.2478/10004-1254-63-2012-2182. PubMed 22450207 ↗
  • Dungdung A, Kumar A, Kumar B, Preetam M, Tara RK, Saba MK. Correlation and prognostic significance of serum amylase, serum lipase, and plasma cholinesterase in acute organophosphorus poisoning. J Family Med Prim Care. 2020 Apr 30;9(4):1873-1877. doi: 10.4103/jfmpc.jfmpc_205_20. eCollection 2020 Apr. PubMed 32670933 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05310188
Lead sponsor
Assiut University
Responsible party
Asmaa AbouBakr Ahmed (director, Assiut University) — Principal investigator
First posted
Apr 4, 2022
Start date
Apr 2022 (estimated)
Primary completion
Feb 2023 (estimated)
Completion
Mar 2023 (estimated)
Last update
Apr 4, 2022

Study contacts

Asmaa AbouBakr Ahmed Ibrahim, Demonstrator
Contact
asmaa.aboubakr99@gmail.com
+201095978353
Nagwa Mahmoud Ali Ghandour, Professor
Contact
n_ghandour10@yahoo.com
+201099977236
Doaa Mohammed Abd EL-Rahman, Ass.Prof
study director · Assiut University
Hanan Sharaf El_Deen Mohammed, Ass.prof
study director · Assiut University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion